Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Lowers Payments For 340B Drugs: Promising Sign For Further Reform?

Nov 02 2017

• By Cathy Kelly

Hospital exterior

Related Content

Closing The Spread: 340B Providers Face Sharp Cuts Under Medicare Proposal

Jul 17 2017

340B Providers Offer Varying Approaches To Tracking, Using Discounts At Hearing

Oct 12 2017

340B Freeze: 'Mega-Guidance' Withdrawn; Clarity On Program Boundaries Delayed Again

Feb 10 2017

Additional Topics

United States Pricing Debate Legislation Government Payers Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.